Monitoring and Evaluation of National Action Plans on AMR. Suggested approaches March 2017

Similar documents
an Indonesia experiences in

Tackling antimicrobial resistance theme 4: Behaviour within and beyond the healthcare setting Call specification

Terms of Reference for Request for Proposals Uganda First Country Grant

GLOBAL HEALTH SECURITY AGENDA ROADMAP FOR ETHIOPIA

Prevention and control of healthcare-associated infections

EU HEALTH POLICY PLATFORM CALL TO ACTION ON ANTIMICROBIAL RESISTANCE (AMR)

CDI case checklist and standard assessment tool. Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36

Antibiotic Awareness Week 2017 Storytelling/Photo essay contest Good practices toward infection freedom

ASEAN Health Cooperation Relevant to the Healthy Development of Children. ASEAN Secretariat

Fleming Fund Grants. Country Grants. Grants. Programme. Regional. Fellowship Scheme. Grants. A central pillar of the Fleming Fund

Joint External Evaluation. of the Democratic Socialist Republic of Sri Lanka. Mission report: June 19-23, 2017

Joint external evaluation of IHR Core Capacities of the Republic of Uganda. Executive summary June 26-30, 2017

Medicines New Zealand

Mauritania Red Crescent Programme Support Plan

Update SRA to SRIA. 28 March Linda van Gaalen

Joint External Evaluation. of TURKMENISTAN. Mission report: June 2016

Resource mobilisation for Antimicrobial Resistance (AMR): Getting AMR into plans and budgets of government and development partners

BSAC STRATEGY ANTIMICROBIAL CHEMOTHERAPY BRITISH SOCIETY FOR

Joint External Evaluation. of the State of Qatar. Mission report: 29 May 2 June 2016

Nursing Home Antimicrobial Stewardship Guide Implement, Monitor, & Sustain a Program

Infection Prevention & Control Prof. Benedetta Allegranzi & the IPC Global Unit team SDS/HIS, WHO HQ

Health and Life Sciences Committee. Advancing the ASEAN Post-2015 Health Development Agenda

January Alberta Infection Prevention and Control Strategy

JOINT EXTERNAL EVALUATION OF IHR CORE CAPACITIES. of the REPUBLIC OF ZAMBIA. Mission report: 7-11 August 2017

abc INFECTION CONTROL STRATEGY

Speaker Biographies Arjun Srinivasan, MD (CAPT, USPHS) Benjamin Chan, MD, MPH, Michael Calderwood, MD, MPH, FIDSA,

Joint External Evaluation. of the Republic of Armenia. Mission report: August 2016

Report of the meeting of the WHO Global Collaborating Centres to support AMR activities globally

JOINT EXTERNAL EVALUATION OF IHR CORE CAPACITIES. of the REPUBLIC OF INDONESIA. Mission report: November 2017

Update on global action plan on WASH in HCF

Are you competent? What prescribers need to know. Janet Flint, National Programme Lead, Population Health and Prevention, Health Education England

Recommendation II. Recommendation I. Who s on Your Team? Recommendation III

IHR JOINT EXTERNAL EVALUATION OF TAIWAN

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

Strengths and weaknesses: existing veterinary legislation

COUNTRY ROADMAP GEORGIA

Leadership Engagement in Antimicrobial Stewardship

Joint External Evaluation. of the Republic of Tunisia. Mission report: 28 November to 2 December 2016

Joint External Evaluation of The Republic of Mozambique

Section 727 of the Carl Levin and Howard P. Buck McKeon National Defense Authorization Act for Fiscal Year 2015 Public Law

ANTIMICROBIAL RESISTANCE IN CANADA

Funding Opportunities with the Standards and Trade Development Facility (STDF) Guidance Note for Applicants

Joint External Evaluation of Sierra Leone

Activity list for infection prevention and control leaders at the facility level

ASEAN-SAARC-WHO Collaboration for implementation of the HPED Project

In , WHO technical cooperation with the Government is expected to focus on the following WHO strategic objectives:

Understanding Antimicrobial Stewardship: Is Your Organization Ready? A S H LEIGH MOUSER, PHARM D, BCPS

Joint External Evaluation. of the REPUBLIC OF KENYA. Mission report: 27 February to 3 March 2017

Commissioning for Quality and Innovation (CQUIN) Guidance for 2016/17 Published March 2016

Joint External Evaluation. of the REPUBLIC OF UGANDA. Mission report: June 26-30, 2017

August 22, Dear Sir or Madam:

August 15, Dear Mr. Slavitt:

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE SYSTEM (GLASS)

For further information please contact: Health Information and Quality Authority

HCAI Local implementation team action plan

Wendy Nicholson National Lead Nurse: Children, Young People and Families Public Health England October 2016

The safety of every patient we care for is our number one priority

PUBLIC HEALTH IN HALTON. Eileen O Meara Director of Public Health & Public Protection

Overview of CDC s Sepsis Activities

GUIDELINES FOR INVESTIGATION OF SUSPICIOUS BIOLOGICAL EVENTS. (guidelines for national veterinary services)

GOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION. National Infection Prevention and Control Policy

Submission to the OIE for official recognition of FMD country status and endorsement of official control programme

QAPI & Infection Prevention: Putting the Pieces Together

Joint External Evaluation. of the United Republic of Tanzania - Zanzibar. Mission report: April 2017

INTERNATIONAL HEALTH REGULATION (IHR) Sumber: Health Security Stewards Fellowship Training Okt 2017

WORLD ALLIANCE FOR PATIENT SAFETY WHO GUIDELINES ON HAND HYGIENE IN HEALTH CARE (ADVANCED DRAFT): A SUMMARY CLEAN HANDS ARE SAFER HANDS

Antimicrobial Stewardship Program in the Nursing Home

RACGP Submission to Developing a National Antimicrobial Resistance Strategy for Australia

Healthcare-Associated Infections

Closing the Labor Supply & Demand Gap

Antimicrobial Resistance Behaviour Change First informal technical consultation 6-7 November, 2017 Château de Penthes, Geneva.

SAARC, Food Security and TADs

JOINT EXTERNAL EVALUATION OF IHR CORE CAPACITIES. of the REPUBLIC OF SOUTH AFRICA. Mission report: 27 November 1 December 2017

Prudent use of antimicrobial agents in human medicine: third report on implementation of the Council recommendation

Proactively prevent HAIs with infection surveillance software

Joint External Evaluation. of the REPUBLIC OF GHANA. Mission report: 6 10 February 2017

In , WHO technical cooperation with the Government is expected to focus on the following WHO strategic objectives:

Introduction to Infection Prevention and Control (IPC) Open Call Series #1 Surveillance

Clean Care is Safer Care: a worldwide priority

Cluster Network Action Plan Neath Cluster. Abertawe Bro Morgannwg University Health Board Neath Cluster Action Plan

You re kidding, right? Patients to help with antimicrobial resistance? December 8, 2016

2/23/2017. Preparing to Meet New Infection Prevention Requirements in Skilled Nursing Facilities. Objectives

San Francisco General Hospital INFECTION CONTROL

Health First Europe calls on the EU Institutions to Champion Patient Safety

Health System Strengthening for Developing Countries

National Health Insurance. Sham Moodley BSc(UCD-Ire),BPharm(UKZN),PDM(HIV/AIDS),MPhil(HIV/AIDS)(SU) F

WHO supports countries to develop responsive and resilient health systems that are centred on peoples needs and circumstances

National Standards for the prevention and control of healthcare-associated infections in acute healthcare services.

The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6)

INFECTION PREVENTION AND CONTROL PROGRAM DESCRIPTION, OUTLINES & OBJECTIVES THE MINISTRY OF HEALTH, SAUDI ARABIA 23 RD 27 TH OCTOBER 2016

THE WHITE HOUSE WASHINGTON

MARY MCGOLDRICK'S PUBLICATIONS

Terms of Reference Kazakhstan Health Review of TB Control Program

Mission report 24 November -1 December 2017

Local Health Department Access to the National Healthcare Safety Network. January 23, 2018

The Core Elements of Antibiotic Stewardship with CMS and QAPI Updates

HEI self-assessment. Completing the self-assessment - Guidance to NHS boards

World Federation for Culture Collections ICCC-12 Conference Florianopolis, Brazil, 26 Sept 1 Oct Dr Nicoletta Previsani

Areas of Focus Statements of Purpose and Goals

Transcription:

Monitoring and Evaluation of National Action Plans on AMR Suggested approaches March 2017

Role of M&E section in AMR plan Help to clarify activities and outputs expected Identify how to monitor progress on priority aspects of the NAP Identify sources of information on progress hopefully many already exist Set out the review process - who will review progress on planned activities, how often?

Scope of M&E in the National Action Plan Immediate priority is to monitor the process of NAP implementation Have the most important planned activities been implemented? If not, what are barriers? Have planned outputs been achieved? Consider how to monitor outcomes and impact Are we having the intended impact on levels of resistance? Reducing use of antibiotics in agriculture? Reducing stock outs of essential medicines in health facilities?

Monitoring the implementation process: link indicators to planned activities Example from a country

Indicators linked to planned activities (2) Another example

Framework for monitoring AMR Global Action Plan

Monitoring each level of the NAP Input Basic resources e.g. Policies, guidelines, standards; funding; human resources; laboratory facilities; equipment and consumables Process Activities e.g. Awareness campaigns, training, surveillance, infection prevention and control measures, drug quality assurance, developing new legislation for stewardship Output Results at level of the program e.g. Implemented programmes and coordination mechanisms, improved laboratory capacity, good laboratory and epidemiological data, trained staff, educated public Outcome Results at level of populations e.g. Greater awareness and knowledge, better behaviour, wider population coverage and access, sustainable financing, moderated consumption, stewardship, use of surveillance data Impact and Goals Ultimate effect in long term Impact: access to antimicrobials, appropriate use, prevalence of AMR and preventable infections, Goals: estimated morbidity and mortality, effective medicines available and affordable, social impact, economic impact

Example for key prevention strategies select indicators and sources Plan Activities Outputs Outcomes Promote farm hygiene, vaccination, biosecurity and appropriate handling of sick animals to prevent transmission of resistant bacteria Develop materials on prevention for large farming enterprises and train trainers Training conducted Source: MOA program Number of large farming enterprises reached with training Source: reporting from districts % of large animal health facilities with improved hygiene practices, vaccination coverage Source: Sample survey Watsan program for health facilities and schools expanded and funded report Progress against plan for building or refurbishing watsan facilities by district Source: watsan program data Number of additional health facilities and schools that have new or refurbished safe water, hygiene and sanitation facilities Source: watsan program data % of health facilities and schools with functional safe water supply, hygiene and sanitation on the premises Source: National facility surveys or HMIS/EMIS

Indicators & tools are available to select from, e.g. AMR surveillance system indicators see GLASS guide to planning, implementation, monitoring and evaluation (WHO, 2016, http://apps.who.int/iris/bitstream/10665/251554/1/who-dgo-amr-2016.4-eng.pdf?ua=1 ) Water and sanitation coverage (SDG indicators) Water and sanitation in health facilities (washinhcf.org indicators, 2016) Core health system indicators (e.g. stock outs, vaccine coverage) WHO new tool for surveys of antimicrobial use in hospitals and pharmacies WHO is working on standard AMR outcome and impact indicators OIE data collection for antimicrobial consumption in animals FAO veterinary laboratory mapping tool

Key messages (1) Priority steps for countries suggested for now: Select priority strategies and activities in the National Action Plan to be implemented first to tackle AMR Identify a manageable number of indicators / measures of progress for these actions, and sources Capture progress that may happening in other projects and programs not directly under AMR

Key messages (2) Suggested approach (continued): Agree how often to monitor and review progress e.g. 6 monthly review against implementation plan by AMR Core Group, annual review by Advisory Committee? As much as possible, draw on standard tools and information systems available In many countries, it may make sense to get started on a few priority activities and monitor these; developing comprehensive implementation plans can come at a later stage